Financhill
Buy
80

MYO Quote, Financials, Valuation and Earnings

Last price:
$6.43
Seasonality move :
104.65%
Day range:
$5.97 - $6.50
52-week range:
$2.51 - $6.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
9.38x
P/B ratio:
20.90x
Volume:
227.4K
Avg. volume:
310.7K
1-year change:
46.24%
Market cap:
$194.2M
Revenue:
$19.2M
EPS (TTM):
-$0.23

Analysts' Opinion

  • Consensus Rating
    Myomo has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $7.04, Myomo has an estimated upside of 19.42% from its current price of $6.42.
  • Price Target Downside
    According to analysts, the lowest downside price target is $5.75 representing 100% downside risk from its current price of $6.42.

Fair Value

  • According to the consensus of 4 analysts, Myomo has 19.42% upside to fair value with a price target of $7.04 per share.

MYO vs. S&P 500

  • Over the past 5 trading days, Myomo has overperformed the S&P 500 by 3.94% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Myomo does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Myomo has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Myomo reported revenues of $9.2M.

Earnings Growth

  • Myomo has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Myomo reported earnings per share of -$0.03.
Enterprise value:
187.6M
EV / Invested capital:
20.18x
Price / LTM sales:
9.38x
EV / EBIT:
--
EV / Revenue:
7.43x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-19.65x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$17.7M
Return On Assets:
-51.97%
Net Income Margin (TTM):
-33.22%
Return On Equity:
-84.04%
Return On Invested Capital:
-84.04%
Operating Margin:
-10.4%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $15.5M $18.5M $25.2M $5.1M $9.2M
Gross Profit $10.7M $12.7M $17.7M $3.5M $6.9M
Operating Income -$11.2M -$8M -$8.4M -$2M -$957.6K
EBITDA -$10.6M -$7.4M -$8M -$1.9M -$836.3K
Diluted EPS -$1.75 -$0.50 -$0.23 -$0.06 -$0.03
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $15.2M $16.5M $11.1M $16M $14.7M
Total Assets $15.4M $17.5M $12.2M $17.1M $16.3M
Current Liabilities $2.2M $3.7M $4.1M $5.8M $7M
Total Liabilities $2.4M $4.3M $4.3M $6M $7M
Total Equity $13M $13.1M $7.8M $11M $9.3M
Total Debt $78K -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -$9.6M -$6.3M -$9M -$1.7M -$1.5M
Cash From Investing -$331.3K -$4.3M $3.9M -$1.3M $2.8M
Cash From Financing $4.8M $10.1M $5.2M $3.9M -$199.5K
Free Cash Flow -$9.7M -$6.4M -$9.5M -$1.8M -$1.8M
MYO
Sector
Market Cap
$194.2M
$46.1M
Price % of 52-Week High
95.18%
46.02%
Dividend Yield
0%
0%
Shareholder Yield
-6.35%
-0.6%
1-Year Price Total Return
46.24%
-30.52%
Beta (5-Year)
1.709
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $6.08
200-day SMA
Buy
Level $4.05
Bollinger Bands (100)
Buy
Level 3.59 - 5.27
Chaikin Money Flow
Sell
Level -89.3M
20-day SMA
Buy
Level $5.91
Relative Strength Index (RSI14)
Buy
Level 65.56
ADX Line
Buy
Level 11.2
Williams %R
Neutral
Level -24.5802
50-day SMA
Buy
Level $4.94
MACD (12, 26)
Buy
Level 0.35
25-day Aroon Oscillator
Buy
Level 60
On Balance Volume
Neutral
Level 216.6M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (5.4088)
Sell
CA Score (Annual)
Level (-2.3008)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (5.0913)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (3)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Stock Forecast FAQ

In the current month, MYO has received 4 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MYO average analyst price target in the past 3 months is $7.04.

  • Where Will Myomo Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Myomo share price will rise to $7.04 per share over the next 12 months.

  • What Do Analysts Say About Myomo?

    Analysts are divided on their view about Myomo share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Myomo is a Sell and believe this share price will drop from its current level to $5.75.

  • What Is Myomo's Price Target?

    The price target for Myomo over the next 1-year time period is forecast to be $7.04 according to 4 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is MYO A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Myomo is a Buy. 4 of 4 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of MYO?

    You can purchase shares of Myomo via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Myomo shares.

  • What Is The Myomo Share Price Today?

    Myomo was last trading at $6.43 per share. This represents the most recent stock quote for Myomo. Yesterday, Myomo closed at $6.42 per share.

  • How To Buy Myomo Stock Online?

    In order to purchase Myomo stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
87
PSIX alert for Dec 26

Power Solutions International [PSIX] is up 6.55% over the past day.

Buy
65
TSLL alert for Dec 26

Direxion Daily TSLA Bull 2X Shares [TSLL] is down 1.98% over the past day.

Buy
75
SMLR alert for Dec 26

Semler Scientific [SMLR] is down 3.2% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock